Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-24-137960

President and CEO sold 100,000 shares at $5.00 ($500,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Sanjiv President and CEO 2024-12-16 Sale 10b5-1 −100,000 $5.00 $500,000 574,548 I: show line 1 in the form
Open-market sales · 100,000 sh · avg $5.00 · $500,000
Loading xslF345X05/ownership.xml…